Global Blood Transfusion Diagnostics Market (2023-2028) by Product Type, Application, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Blood Transfusion Diagnostics Market (2023-2028) by Product Type, Application, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis


Introduction

The Global Blood Transfusion Diagnostics Market is estimated to be USD 4.96 Bn in 2023 and is expected to reach USD 6.13 Bn by 2028 growing at a CAGR of 4.31%.
Market Dynamics
Market dynamics are forces that impact the prices and behaviours of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.
As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Blood Transfusion Diagnostics Market is segmented based on Product Type, Application, End-User, and Geography.
By Product Type, the market is classified into Reagents & Kits, Instruments, and Others.
By Application, the market is classified into Blood Grouping and Disease Screening.
By End-User, the market is classified into Hospitals, Blood Banks, Diagnostic Laboratories, Plasma Fractionation Companies, and Others.
By Application, the market is classified into Bottles, Ampoules, Vials, and Prefilled Syringes & Injectables.
By End Users, the market is classified into Pharmaceuticals, Food & Beverage, Cosmetic Personal Care, and Others
By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are F. Hoffmann-La Roche, Fujirebio Diagnostics, Grifols S.A., Hologic Inc, etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Blood Transfusion Diagnostics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
Infogence Global Research analyses the Global Blood Transfusion Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?

The report offers a comprehensive evaluation of the Global Blood Transfusion Diagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.

Report Highlights
:
A complete analysis of the market, including parent industry
Important market dynamics and trends

Market segmentation

Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market


1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Blood-Related Disorders and Transfusion-Transmitted Infections
4.1.2 Growing Blood Donation Campaigns
4.1.3 Rising Cases of Road Accidents, Trauma, and Surgeries
4.2 Restraints
4.2.1 Lack of Sufficient Blood Donations
4.2.2 High Operating Cost and Strict Regulatory Policies for Approval
4.3 Opportunities
4.3.1 Demand for Technologically Advanced Screening Analyzers in Developing Countries
4.3.2 Integration of Approved Instrument Assays in Laboratories and Hospitals
4.4 Challenges
4.4.1 Availability of Alternative Treatments
4.4.2 Limited Infrastructure and Skilled Professional
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Blood Transfusion Diagnostics Market, By Product Type,
6.1 Introduction
6.2 Reagents & Kits
6.3 Instruments
6.4 Others
7 Global Blood Transfusion Diagnostics Market, By Application
7.1 Introduction
7.2 Blood Grouping
7.3 Disease Screening
7.3.1 Molecular Disease Screening
7.3.2 Serological Disease Screening
8 Global Blood Transfusion Diagnostics Market, By End-User
8.1 Introduction
8.2 Hospitals
8.3 Blood Banks
8.4 Diagnostic Laboratories
8.5 Plasma Fractionation Companies
8.6 Others
9 Americas' Blood Transfusion Diagnostics Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe's Blood Transfusion Diagnostics Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa's Blood Transfusion Diagnostics Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC's Blood Transfusion Diagnostics Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 IGR Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Abbott Laboratories
14.2 BAG Health Care GmbH
14.3 Beckman Coulter Inc.
14.4 Becton, Dickinson, and Company
14.5 Werfen
14.6 Bio-Rad Laboratories, Inc.
14.7 Danaher Corporation
14.8 DiaSorin S.p.A.
14.9 F. Hoffmann-La Roche AG
14.10 Fujirebio Diagnostics, Inc.
14.11 Grifols, S.A.
14.12 Merck KGaA
14.13 Boekel Scientific
14.14 Hologic, Inc.
14.15 Immucor, Inc.
14.16 Lorne Laboratories Limited
14.17 Novartis International AG
14.18 Ortho Clinical Diagnostics
14.19 Quotient Limited
14.20 Quidel Corporation
14.21 Siemens Healthineers AG
14.22 Omnia Health
14.23 Thermo Fisher Scientific
15 Appendix
15.1 Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings